Doctorcrypto About RSS Subscribe
Doctorcrypto
HomeBusiness › CFTC asks judge to dismiss CME lawsuit over crypto perpetual futures
Business

CFTC asks judge to dismiss CME lawsuit over crypto perpetual futures

By Diego Whitfield · · 2 min read

The U.S. Commodity Futures Trading Commission has asked a federal judge to throw out a lawsuit filed by CME Group over the regulator's approach to crypto perpetual futures, dismissing the exchange operator's complaint as an overreaction to a policy that ultimately benefits it.

The Regulator's Position

In its filing, the CFTC characterized the dispute as "much ado about nothing," arguing that CME's grievances lack legal merit. The agency emphasized that its order does not exclude the exchange giant from participating in the market for these products.

According to the regulator, the framework in question permits any designated contract market — a category that includes CME itself — to list crypto perpetual futures. That inclusivity, the CFTC contends, undercuts the basis for CME's legal challenge.

The regulator insists the entire dispute amounts to "much ado about nothing."

What's at Stake

Perpetual futures have become a popular instrument in cryptocurrency trading, particularly on offshore platforms, because they lack a traditional expiration date. Their potential arrival in regulated U.S. markets represents a significant expansion of the products available to domestic traders.

CME's lawsuit reflects the competitive tensions that arise as regulators open the door to novel crypto derivatives. The outcome could shape how established exchanges and newer entrants alike bring these offerings to American investors.

The CFTC's motion to dismiss now puts the matter before a federal judge, who will weigh whether the case can proceed. Key considerations include:

  • Whether CME has standing to challenge the order
  • How the framework treats designated contract markets
  • The broader regulatory path for crypto perpetual futures in the U.S.

A ruling in the CFTC's favor would clear the way for the agency's approach to move forward, while a decision allowing the suit to continue could prolong uncertainty over how these products enter regulated markets.

Was this useful?👍 Yes👎 No